New hope for breast cancer patients: drug combo may stop return of disease
Disease control
Recruiting now
This study tests whether adding the drug abemaciclib to standard hormone therapy can help prevent breast cancer from returning in people whose cancer came back in the same area (chest, breast, or nearby lymph nodes) after initial treatment. About 290 participants with a specific …
Phase: PHASE3 • Sponsor: Japanese Foundation for Cancer Research • Aim: Disease control
Last updated May 01, 2026 16:00 UTC